Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis (Q36541529)
Jump to navigation
Jump to search
scientific article published on March 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis |
scientific article published on March 2016 |
Statements
Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis (English)
Dong Ling Xu
Xiao Bo Liu
Shao Jie Bi
Tong Zhao
Shu Jian Sui
Xiao Ping Ji
1 reference
1 reference
1 reference